Hyunkyung Jeong

Title: Hyunkyung Jeong: Innovator in Antibody Development

Introduction

Hyunkyung Jeong is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins associated with neurodegenerative diseases.

Latest Patents

Hyunkyung Jeong holds a patent for "Anti-acetylated huntingtin antibodies and uses thereof." This invention includes methods for preparing acetylated Huntingtin (Htt) polypeptides, acetylated Htt polypeptide antigens, and antibodies that specifically recognize acetylated epitopes on Htt polypeptides. The patent also details the preparation and use of antibodies that bind to acetylated epitopes on Htt polypeptides, particularly when the acetylated residue corresponds to the K444 residue of the full-length, wild-type Htt polypeptide. Additionally, the invention encompasses hybridoma cell lines that produce antibodies specifically binding to acetylated Htt polypeptides.

Career Highlights

Hyunkyung Jeong is affiliated with The General Hospital Corporation, where he continues to advance research in his field. His work has implications for understanding and potentially treating conditions related to Huntington's disease.

Collaborations

He has collaborated with esteemed colleagues such as Dimitri Krainc and Florian Then, contributing to a rich environment of innovation and research.

Conclusion

Hyunkyung Jeong's work in developing targeted antibodies represents a significant advancement in biotechnology, with the potential to impact therapeutic strategies for neurodegenerative diseases. His contributions are vital to the ongoing research in this critical area of health.